Real-world application of amikacin liposome inhalation in managing complex mycobacterium avium pulmonary conditions

被引：0
|
作者：
Yanagihara, Toyoshi [1 ]
Mori, Asami [2 ]
Ogata, Hiroaki [1 ]
Kadowaki, Masako [3 ]
Moriuchi, Yuki [1 ]
Ishimatsu, Akiko [1 ]
Otsuka, Junji [1 ]
Taguchi, Kazuhito [1 ]
Moriwaki, Atsushi [1 ]
Yoshida, Makoto [1 ]
机构：
[1] NHO Fukuoka Natl Hosp, Dept Resp Med, Fukuoka, Japan
[2] NHO Fukuoka Natl Hosp, Dept Pharm, Fukuoka, Japan
[3] NHO Fukuoka Natl Hosp, Dept Infect Dis, Fukuoka, Japan
来源：
RESPIROLOGY | 2024年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP15-006
引用
收藏
页码：223 / 223
页数：1
相关论文
共 50 条
  • [41] Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease A NTM-NET study
    Zweijpfenning, Sanne Maria Henriette
    Chiron, Raphael
    Essink, Sharon
    Schildkraut, Jodie
    Akkerman, Onno W.
    Aliberti, Stefano
    Altenburg, Josje
    Arets, Bert
    van Braeckel, Eva
    Delaere, Benedicte
    Gohy, Sophie
    Haarman, Eric
    Lorent, Natalie
    McKew, Genevieve
    Morgan, Lucy
    Wagner, Dirk
    van Ingen, Jakko
    Hoefsloot, Wouter
    CHEST, 2022, 162 (01) : 76 - 81
  • [42] The treatment outcomes of cavitary Mycobacterium avium complex pulmonary disease according to the use of amikacin or streptomycin
    Kim, Seong Min
    Shim, Tae Sun
    Jo, Kyung-Wook
    RESPIROLOGY, 2023, 28 : 204 - 204
  • [43] Challenges in achieving the guideline-recommended amikacin level for Mycobacterium avium complex pulmonary disease
    Akutsu, Takuya
    Tone, Kazuya
    Hasegawa, Airi
    Kitayama, Takaaki
    Inaki, Shunsuke
    Gochi, Mina
    Takagi, Masamichi
    Araya, Jun
    JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2025, 39
  • [44] Comparison of Treatment Outcomes of Cavitary Mycobacterium avium Complex Pulmonary Disease with Streptomycin or Amikacin Use
    Kim, Seong Min
    Chong, Yong Pil
    Lee, Hyun Joo
    Shim, Tae Sun
    Jo, Kyung-Wook
    MICROBIOLOGY SPECTRUM, 2023, 11 (03)
  • [45] Early-Phase Adverse Effects and Management of Liposomal Amikacin Inhalation for Ref ractory Mycobacterium avium Co m p l ex Lung Disease in Real-World Settings
    Morita, Atsuho
    Namkoong, Ho
    Yagi, Kazuma
    Asakura, Takanori
    Hosoya, Makoto
    Tanaka, Hiromu
    Lee, Ho
    Ogawa, Takunori
    Kusumoto, Tatsuya
    Azekawa, Shuhei
    Nakagawara, Kensuke
    Kamata, Hirofumi
    Ishii, Makoto
    Fukunaga, Koichi
    Ozawa, Hiroyuki
    Hasegawa, Naoki
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 4001 - 4011
  • [46] ENHANCED EFFECT OF LIPOSOME-ENCAPSULATED AMIKACIN ON MYCOBACTERIUM-AVIUM-M INTRACELLULARE COMPLEX INFECTION IN BEIGE MICE
    DUZGUNES, N
    PERUMAL, VK
    KESAVALU, L
    GOLDSTEIN, JA
    DEBS, RJ
    GANGADHARAM, PRJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (09) : 1404 - 1411
  • [47] Impact of initiation of amikacin liposome inhalation suspension on hospitalizations and other healthcare resource utilization measures: a retrospective cohort study in real-world settings
    Timothy Aksamit
    Jasmanda Wu
    Mariam Hassan
    Emily Achter
    Anjan Chatterjee
    BMC Pulmonary Medicine, 22
  • [48] Impact of initiation of amikacin liposome inhalation suspension on hospitalizations and other healthcare resource utilization measures: a retrospective cohort study in real-world settings
    Aksamit, Timothy
    Wu, Jasmanda
    Hassan, Mariam
    Achter, Emily
    Chatterjee, Anjan
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [49] ALIS (Amikacin Liposome Inhalation Suspension) for the Treatment of Patients with Refractory Mycobacterium avium Complex Lung Disease (MACLD) the Number Needed to Treat (NNT) and Number Needed to Harm (NNH)
    Marras, T. K.
    Hassan, M.
    Mange, K. C.
    Ciesielska, M.
    Sonnenahalli, S. Dhar
    Jumadilova, Z.
    Chatterjee, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [50] DIFFERENTIAL-EFFECTS OF FREE AND LIPOSOME ENCAPSULATED AMIKACIN ON THE SURVIVAL OF MYCOBACTERIUM-AVIUM COMPLEX IN MOUSE PERITONEAL-MACROPHAGES
    KESAVALU, L
    GOLDSTEIN, JA
    DEBS, RJ
    DUZGUNES, N
    GANGADHARAM, PRJ
    TUBERCLE, 1990, 71 (03): : 215 - 218
12345